Vincerx Pharma Receivables

Vincerx Pharma (VINC) currently reports a receivables of $0 as of March 2025. That compares with $1M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Vincerx Pharma's receivables history and peer comparisons.

Vincerx Pharma's receivables decreased from $1M to $0 — a 100.0% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vincerx Pharma reported $0 in receivables as of March 2025. That compares with $1M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vincerx Pharma, and consider following VINC for alerts when major investors trade the stock.

Vincerx Pharma is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VINC with unrelated industries.